Development of predictive tools to assess capping tendency of tablet formulations

被引:50
|
作者
Akseli, Ilgaz [1 ]
Ladyzhynsky, Nadia [1 ]
Katz, Jeffrey [1 ]
He, Xiaorong [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, R&D Pharmaceut Dev, Ridgefield, CT 06877 USA
关键词
Capping; Compaction; Ultrasonic testing; Bonding; Elastic recovery; Anisotropic properties; MECHANICAL-PROPERTIES; TENSILE-STRENGTH; PARACETAMOL; PRESSURE; COMPRESSION; ANISOTROPY;
D O I
10.1016/j.powtec.2012.04.026
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Capping is one of the mechanical defects in the tableting process in which catastrophic failure of the compact can occur. Understanding what influences tablet capping in terms of process variables, material properties, and density/stress distributions in tablets and developing specialized techniques to correlate these variables with mechanical failures are practical interests of the pharmaceutical industry. In this article, a nondestructive ultrasonic method as well as a derived Cap Value to predict the capping tendencies of tablet formulations was developed. In the ultrasonic method, effective elastic (E) and shear (G) moduli of each tablet in axial and radial directions were characterized. The ultrasonic measurements revealed that elastic and shear modulus values vary with different testing orientations which indicated elastic and shear moduli anisotropy in tablets. The anisotropic properties of tablet formulations are represented by a dimensionless value (EG). It was found that as the EG ratio decreases; the compressed powder exhibited an increasing level of anisotropic nature, which led to a higher tendency for capping. A formulation with a higher Cap Value seemed to have a higher likelihood for capping. Acceptance criteria of the Cap Value and EG ratio have been proposed based on manufacturing performance. A systematic approach has been applied to develop predictive tools to assess capping tendencies of formulations. These tools have been shown to correlate well with actual capping performance of a diverse sample set. The developed tools are fast, material sparing and have potential to flag the risk of capping issues and provide insight into the performance of common materials during formulation and process development. Application of these tools may help reduce development time, API usage and facilitate development of a robust product. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 50 条
  • [41] Development, Optimization, and Validation of a Novel HPLC Method for Simultaneous Quantification of Artesunate and Amodiaquine in Tablet Formulations
    Echerfaoui, Fouad
    Bouchafra, Houda
    El Bourakadi, Khadija
    El Orche, Aimen
    El Kacemi, Mounir
    Benomar, Abdelhafid
    Karrouchi, Khalid
    Bouatia, Mustapha
    El Karbane, Miloud
    METHODS AND OBJECTS OF CHEMICAL ANALYSIS, 2023, 18 (01): : 42 - 50
  • [42] Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations
    Guhmann, Marie
    Preis, Maren
    Gerber, Frederic
    Poellinger, Norbert
    Breitkreutz, Joerg
    Weitschies, Werner
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (04) : 540 - 551
  • [43] Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration
    Nellore, RV
    Rekhi, GS
    Hussain, AS
    Tillman, LG
    Augsburger, LL
    JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) : 247 - 256
  • [44] Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex
    Bonferoni, MC
    Rossi, S
    Ferrari, F
    Caramella, C
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2004, 9 (02) : 155 - 162
  • [45] Reactive Metabolites in Early Drug Development: Predictive In vitro Tools
    Pelkonen, Olavi
    Pasanen, Markku
    Tolonen, Ari
    Koskinen, Mikko
    Hakkola, Jukka
    Abass, Khaled
    Laine, Jaana
    Hakkinen, Merja
    Juvonen, Risto
    Auriola, Seppo
    Storvik, Markus
    Huuskonen, Pasi
    Rousu, Timo
    Rahikkala, Maiju
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (04) : 538 - 550
  • [46] Development of Participatory Tools to Assess Physical Activity in Rural Areas in Austria
    Hofer, Kathrin
    Tuttner, Silvia
    Unger, Julia
    Helms, Katja
    Hoedl, Josef
    van Poppel, Mireille N. M.
    JOURNAL OF TRANSPORT & HEALTH, 2017, 5 : S97 - S98
  • [47] Development and validation of tools to assess genetic discrimination and genetically based racism
    Parrott, RL
    Silk, KJ
    Dillow, MR
    Krieger, JL
    Harris, TM
    Condit, CM
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2005, 97 (07) : 980 - 990
  • [48] Development and validation of tools to assess food additive intake: the ENIGMA study
    Trakman, G.
    Lin, W. Y. Y.
    Wilson-O'brien, A.
    Ching, J.
    Tang, W.
    Orr, L.
    Stanley, A.
    Hamilton, A. L.
    Morrison, M.
    Yu, J.
    Sung, J. J.
    Ng, S. C.
    Kamm, M. A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S507 - S507
  • [50] Development of a predictive normogram to assess the risk of liver steatosis in childhood obesity
    Martos-Moreno, Gabriel A.
    Maria Andres-Esteban, Eva
    Martinez-Villanueva, Julian
    Sirvent, Sara
    Hawkins, Federico G.
    Argente, Jesus
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 270 - 271